Chenqi Xu is now a principle investigator and assistant director at Shanghai Institute of Biochemistry (SIBCB), Chinese Academy of Sciences. He oversees the graduate and postdoctoral office. He also serves as a deputy director of State Key Laboratory of Molecular Biology.
Chenqi Xu received his B.S. in Biochemistry from East China Normal University in 1998. He completed his PhD training in protein chemistry with Dr. Chengwu Chi in 2004 at SIBCB. A part of his PhD work was done in University of Leuven and University of Hasselt in Belgium, under supervision of Drs. Jan Tytgat and Emmy Van Kerkhove. He then received postdoctoral training in immunology with Dr. Kai Wucherpfennig at Dana Farber Cancer Institute, Harvard Medical School. In 2009, he moved back to SIBCB to start his independent career.
Dr. Xu grew up at a beautiful town of Zhejiang Province and he enjoyed mountain hiking during his childhood. He is a fan of soccer and his ultimate wish is China can win the world cup someday.
Assistant Research
liuxiwei2015@sibcb.ac.cn
Assistant Research
zhouqiuping@ucas.ac.cn
Associate Professor
lihua@sibcb.ac.cn
Research Associate
xulab@sibcb.ac.cn
Assistant Research
tliang@ucas.ac.cn
wangqsh@ shanghaitech.edu.cn
xuxinyi2018@sibcb.ac.cn
liukexin2019@sibcb.ac.cn
zhenglin2019@sibcb.ac.cn
renzhengxu2020@sibcb.ac.cn
yinmingyang2020@sibcb.ac.cn
xuxiangyan2021@sibcb.ac.cn
yanghaochen2021@sibcb.ac.cn
zhangym2@shanghaitech.edu.cn
xumingwen22@mails.ucas.ac.cn
lukeze21@mails.ucas.ac.cn
wangxin223@mails.ucas.ac.cn
linzuomiao21@mails.ucas.ac.cn
caokexin2022@sibcb.ac.cn
zhangzhihan2023@sibcb.ac.cn
zhoulin23@mails.ucas.ac.cn
niuyidan23@mails.ucas.ac.cn
zhaoyalei23@mails.ucas.ac.cn
zhuyiming2023@sibcb.ac.cn
Ph.D. Student,Institut Curie (M.S., 2014-2017)
Immuno Therapy Investigator, Epigenic Therapeutic Inc, Shanghai (MD, 2015-2021)
Guangzhou Huangpu District Bureau of Science and Technology(M.S., 2016-2020)
Professor, Jilin University (Ph.D., 2013-2020)
Postdoc, German Cancer Research Center (PhD., 2010-2017)
Investment Manager, M.Eng., ZJHC Venture Capital. (M.S., 2010-2013)
Field Applications Scientist, Curiox Biosystems, Singapore (M.S., 2015-2018)
Associate Scientist, Johnson and Johnson China R&D Center (M.S., 2012-2016)
Investment Director, Jangsu Tenykinho Investment Management Co.,Ltd..( M.S., 2013-2016)
Technical support, Pfizer CRDC. (M.S., 2011-2015)
Professor, Southern Medical University. (PostDoc, 2013-2016; PhD., 2007-2013)
Professor, Shenzhen Institute of Advanced Technology,CAS. (PhD., 2009-2014)
Senior Scientist II, Shanghai WuXi Biologics. (PostDoc, 2014-2017; PhD., 2009-2014)
PhD. Candidate, Shanghai Pulmonary Hospital (M.S., 2009-2013)
Scientist, Milestone Biotechnologies (PhD., 2017-2024)
Postgraduate, a Biology teacher in Shenzhen Academy of International Education(M.S., 2016-2020)
Postdoc,UT Southwestern Medical Center (PhD.,2019-2024)
Sr. Manager, JW Therapeutics (Postdoc, 2018-2022; Ph.D., 2011-2018)
Senior Research Engineer, Immunochina (Postdoc, 2018-2020)
Professor, Shandong University(PhD., 2011-2018)
Postdoc, Duke University (Postdoc, 2019-2023; PhD., 2012-2019)
Ph.D. Student,Shanghai Jiao Tong University School of Medicine (M.S., 2020-2023)
Research Assistant, ZhongShan Institute for Drug Discovery (M.S., 2020-2023)